Country
United Kingdom
Astra Zeneca Plc has announced the publication on 8 December of interim Phase 3 data of a Covid-19 vaccine that it is developing with the University of Oxford in The Lancet. The interim analysis for efficacy and safety, as outlined in the article,
Full text available to subscribers only. Click here for information on subscribing to MedNous.